PLUS THERAPEUTICS, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
The company mentioned on its website that they use animals for product testing.
“PLUS THERAPEUTICS’ DRNL™ is a radiotherapeutic consisting of a BMEDA-chelated 186-rhenium radiation particle co-encapsulated with doxorubicin within a nanoliposome. DRNL™ is currently being evaluated in preclinical animal studies for squamous cell carcinoma of the head and neck.” Read the following article
Company Website: https://www.plustherapeutics.com